Skip to main content

Table 1 Patient characteristics

From: Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia

Feature Total CRT No CRT
  Number of patients (%)
Total 82 (100) 31(38) 51(62)
Gender:    
Female 37 (45) 16 (20) 21(26)
Male 45 (55) 15 (18) 30 (36)
ALL status:    
First complete remission 79 (96) 29 (35) 50 (61)
Relapses 3 2 1
CNS 1 1 0
Testes 2 1 1
BM + CNS 0 0 0
Intensity of protocol:    
High intensity 14 (17) 13 (16) 1 (1)
Standard intensity 68 (83) 18 (22) 50 (61)
Age at diagnosis(years) 1-16,9 1,9-13,7 1-16,9
Median 4,5 4,2 4,8
Age at study (years) 4,8-26,2 4,8-26,2 5,6-24,2
Median 13,2 17,7 11,4
Time from the start of 0,9-20,7 2,8-20,7 0,9-10,4
ALL treatment (years)    
Median 7,8 12,7 6,1
Time from completion of ALL treatment (years) 0,5-4,3 1,8-4,3 0,5-3,4
Median 3,2 2,7 3,2
  1. ALL - acute lymphoblastic leukemia; CRT - cranial radiotherapy